Biomarkers and Precision Medicine Community (BPMC)

Please join us for an Open Scientific Discussion (OSD) hosted by the AAPS Therapeutic Product Immunogenicity (TPI) and Biomarkers and Precision Medicine (BPM) Communities on February 21^st, 12 - 1 pm ET on the following topic:

Characterizing CD4 T Cell Immune Responses (Part 2)

·       What are the complementary assays to a CD4 T cell assay for integrated immunogenicity risk assessment?

·       What are the key parameters and considerations for preclinical immunogenicity assays?

·       How to qualify a CD4 T cell assay?

Discussion Leaders:

Sophie Tourdot (Pfizer), Sofie Denies (ImmunXperts), Chloe Ackaert (ImmunXperts), and Sofie Pattyn (ImmunXperts)

Organized by:  Yi Wen (Lilly), Vibha Jawa (BMS), Carmen Fernández-Metzler (PharmaCadence) and Karen Quadrini (Prothena Biosciences)

We start at 12:00 ET sharp. To avoid interruptions, please dial in before noon and mute yourself until Q&A starts.

(Please remain on mute unless asking questions)

When: Wed, Feb 21, 2024, 12 pm – 1 pm ET

Where: Please join from your computer, tablet or smartphone.
https://global.gotomeeting.com/join/305789893

You can also dial in using your phone.
United States: +1 (872) 240-3412
Access Code: 305-789-893
Join from a video-conferencing room or system.
Dial in or type: 67.217.95.2 or inroomlink.goto.com
Meeting ID: 305 789 893
Or dial directly: [email protected] or 67.217.95.2##305789893
New to GoToMeeting? Get the app now and be ready when your first meeting starts:
https://global.gotomeeting.com/install/305789893

Please feel free to share with colleagues who may be interested in this topic.

Thank you,

The Leadership Teams of the AAPS TPI and BPM Communities

Thank you for sharing this, @Karen Quadrini! Was this session recorded? Also tagging @Dipankar Chaudhuri to keep everyone aligned. Thank you, all!

Please join us for an Open Scientific Discussion (OSD) hosted by the AAPS Therapeutic Product Immunogenicity (TPI) and Biomarkers and Precision Medicine (BPM) Communities on February 21^st, 12 - 1 pm ET on the following topic:

Characterizing CD4 T Cell Immune Responses (Part 2)

·       What are the complementary assays to a CD4 T cell assay for integrated immunogenicity risk assessment?

·       What are the key parameters and considerations for preclinical immunogenicity assays?

·       How to qualify a CD4 T cell assay?

Discussion Leaders:

Sophie Tourdot (Pfizer), Sofie Denies (ImmunXperts), Chloe Ackaert (ImmunXperts), and Sofie Pattyn (ImmunXperts)

Organized by:  Yi Wen (Lilly), Vibha Jawa (BMS), Carmen Fernández-Metzler (PharmaCadence) and Karen Quadrini (Prothena Biosciences)

We start at 12:00 ET sharp. To avoid interruptions, please dial in before noon and mute yourself until Q&A starts.

(Please remain on mute unless asking questions)

When: Wed, Feb 21, 2024, 12 pm – 1 pm ET

Where: Please join from your computer, tablet or smartphone.
https://global.gotomeeting.com/join/305789893

You can also dial in using your phone.
United States: +1 (872) 240-3412
Access Code: 305-789-893
Join from a video-conferencing room or system.
Dial in or type: 67.217.95.2 or inroomlink.goto.com
Meeting ID: 305 789 893
Or dial directly: [email protected] or 67.217.95.2##305789893
New to GoToMeeting? Get the app now and be ready when your first meeting starts:
https://global.gotomeeting.com/install/305789893

Please feel free to share with colleagues who may be interested in this topic.

Thank you,

The Leadership Teams of the AAPS TPI and BPM Communities

Thanks for asking, @Stacey Axler!  The session was recorded.  The recording and a PDF copy of the presentation has been uploaded to the BPM Community library for on demand access.  The files in the library can be accessed directly through the link below.

21 Feb 2024 OSD: Characterizing CD4 T Cell Immune Responses (Part 2)

Many thanks to the presenters and attendees for the robust discussion!   

Thank you for sharing this, @Karen Quadrini! Was this session recorded? Also tagging @Dipankar Chaudhuri to keep everyone aligned. Thank you, all!

Please join us for an Open Scientific Discussion (OSD) hosted by the AAPS Therapeutic Product Immunogenicity (TPI) and Biomarkers and Precision Medicine (BPM) Communities on February 21^st, 12 - 1 pm ET on the following topic:

Characterizing CD4 T Cell Immune Responses (Part 2)

·       What are the complementary assays to a CD4 T cell assay for integrated immunogenicity risk assessment?

·       What are the key parameters and considerations for preclinical immunogenicity assays?

·       How to qualify a CD4 T cell assay?

Discussion Leaders:

Sophie Tourdot (Pfizer), Sofie Denies (ImmunXperts), Chloe Ackaert (ImmunXperts), and Sofie Pattyn (ImmunXperts)

Organized by:  Yi Wen (Lilly), Vibha Jawa (BMS), Carmen Fernández-Metzler (PharmaCadence) and Karen Quadrini (Prothena Biosciences)

We start at 12:00 ET sharp. To avoid interruptions, please dial in before noon and mute yourself until Q&A starts.

(Please remain on mute unless asking questions)

When: Wed, Feb 21, 2024, 12 pm – 1 pm ET

Where: Please join from your computer, tablet or smartphone.
https://global.gotomeeting.com/join/305789893

You can also dial in using your phone.
United States: +1 (872) 240-3412
Access Code: 305-789-893
Join from a video-conferencing room or system.
Dial in or type: 67.217.95.2 or inroomlink.goto.com
Meeting ID: 305 789 893
Or dial directly: [email protected] or 67.217.95.2##305789893
New to GoToMeeting? Get the app now and be ready when your first meeting starts:
https://global.gotomeeting.com/install/305789893

Please feel free to share with colleagues who may be interested in this topic.

Thank you,

The Leadership Teams of the AAPS TPI and BPM Communities